| Identification | Back Directory | [Name]
2,6-PIPERAZINEDIONE, 4,4'-(1-METHYL-1,2-ETHANEDIYL)BIS- | [CAS]
21416-87-5 | [Synonyms]
ICRF
Razoxin
Zinecard
ICRF-159
ICRF-187
Razoxane
Eucardion
ICI-59118
NSC-129943
NSC-169780
NCI-C-01627
rac-ICRF-159
PropylenediamineTetraacetylimide
2,6-Piperazinedione, 4,4'-propylenedi-
(±)-1，2-Bis(3，5-diox-opiperazinyl)propane
2,6-Piperazinedione, 4,4'-propylenedi-, (+-)-
2,6-Piperazinedione, 4,4'-propylenedi-, (.+-.)-
(+-)-(3,5,3',5'-Tetraoxo)-1,2-dipiperazinopropane
.+-.-(3,5,3',5'-Tetraoxo)-1,2-dipiperazinopropane
2,6-PIPERAZINEDIONE, 4,4'-(1-METHYL-1,2-ETHANEDIYL)BIS-
(±)-4,4'-(1-Methyl-1,2-ethanediyl)bis(2,6-piperazinedione)
2,6-PIPERAZINEDIONE, 4,4'-(1-METHYL-1,2-ETHANEDIYL)BIS- USP/EP/BP | [Molecular Formula]
C11H16N4O4 | [MDL Number]
MFCD01702985 | [MOL File]
21416-87-5.mol | [Molecular Weight]
268.27 |
| Chemical Properties | Back Directory | [Melting point ]
233.5°C | [Boiling point ]
411.43°C (rough estimate) | [density ]
1.2576 (rough estimate) | [refractive index ]
1.6081 (estimate) | [storage temp. ]
Refrigerator | [solubility ]
DMSO (Slightly) | [form ]
Solid | [color ]
White |
| Safety Data | Back Directory | [Safety Profile]
Suspected carcinogen
with experimental carcinogenic and
tumorigenic data. Moderately toxic by
intraperitoneal route. Experimental
teratogenic and reproductive effects. Human
systemic effects by ingestion: nausea,
thrombocytopenia, leukopenia. Mutation
data reported. When heated to
decomposition it emits toxic fumes of NOx. |
|
| Company Name: |
LGM Pharma
|
| Tel: |
1-(800)-881-8210 |
| Website: |
www.lgmpharma.com |
| Company Name: |
Venkat Pharma
|
| Tel: |
08048372463Ext 224 |
| Website: |
http://www.approvedhomemanagement.com/ShowSupplierProductsList1152079/0.htm |
|